Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Biochemistry Analyzer

By Drug Discovery Trends Editor | September 2, 2008

innovatis Inc. introduces CuBiAn, a fully-automated, membrane-free chemical analyzer that measures key parameters in cell culture media, including IgG. As a proven, established technology, the automated capabilities and membrane-free technology of CuBiAn allow for robust usage and high reproducibility, with very low operating costs in calibration and maintenance. All assays are prepared, incubated, and measured by the instrument. Pipetting, sample pre-dilution, and temperature control are all automated to provide significant assay ranges (IgG 10ug/ml – >20 g/L).

The CuBiAn can detect IgG concentrations along with 11 different metabolites in a single sample and sequence. IgG is detected by immuno-turbidimetry, while all other molecules are quantified by photometric enzyme assays. This wide measurement range allows for a nearly unlimited flexibility for new assay methods. The key parameters measured are IgG (human, humanized), glucose, lactate, ammonia, glutamine, glutamate, inorganic phosphate, LDH, total protein, and Na+, K+, Cl-. Barcode detection of samples and reagents ensure traceable analysis results. CuBiAn requires low sample volumes, and is capable of providing 90 results per hour (and 360 results with an ISE unit).

The innovatis CuBiAn photometric biochemistry analyzer and Cedex HiRes high-performance cell counter are engineered and designed to integrate with the BaychroMAT CellCount, an online fermentation monitoring automation platform co-developed with Bayer Technology Services. It features a sterile sampling system suitable for implementation with existing bioreactors, and data management software that interfaces with existing MES and LIMS process control.

innovatis


Filed Under: Drug Discovery

 

Related Articles Read More >

EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE